The Archive · 1 posts
Discover breakthrough therapies! 🚀 Nuformix PLC (NFX) pioneers innovative drug development on the LSE, transforming patient care. 🌿
Nuformix advances NXP002 for lung fibrosis with EU orphan status, but auditors flag going concern risk as cash runs low.
Showing 0 of 1 posts
January 27, 2026